Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
PharmaBlock Appoints Dr. Zhengtian Gu as Senior Vice President of Quality and Regulatory Affairs 2022-02-16 20:00
JIXING ANNOUNCES RECEIPT OF BREAKTHROUGH THERAPY DESIGNATION FOR AFICAMTEN IN CHINA 2022-02-16 18:06
Sirnaomics Receives Safe to Proceed Letter for U.S. FDA Investigational New Drug Application for Systemic RNAi Therapeutic STP707 in Primary Sclerosing Cholangitis (PSC) 2022-02-16 17:04
NIBIOHN, Shionogi Discover Host Immune-dependent Novel Anti-coronavirus Antibody 2022-02-16 14:00
A Breakthrough in Probiotic Therapy - Personalized Probiotics (Dispensing) Machine for a Balanced and Enhanced Immune System 2022-02-16 10:00
Travecta Therapeutics Appoints Leading Experts to Expand its Scientific Advisory Leadership Team 2022-02-15 21:00
Travecta Therapeutics Appoints Leading Experts to Expand its Scientific Advisory Leadership Team 2022-02-15 21:00
HPG: New Breakthrough in Virus Inactivation with Green Tea Catechin (EGCg) 2022-02-15 16:00
AffaMed Therapeutics Announces IND Clearance by US FDA for AM712 - a Novel Bispecific Biologic for the Treatment of Retinal Vascular Diseases 2022-02-15 15:05
G-NiiB probiotics - world's first microbiome-based immunity formulas now available at IMI 2022-02-15 09:30
Shanghai Public Health Clinical Center Initiated Functional Cure Study of Anti-PD-L1 Antibody ASC22 (Envafolimab) in Combination With Chidamide in HIV-Infected Patients 2022-02-14 17:34
U.S. FDA Grants Orphan Drug Designation to BCMA CAR-T Cell Therapy Co-Developed by IASO Bio and Innovent 2022-02-14 08:25
U.S. FDA Grants Orphan Drug Designation to BCMA CAR-T Cell Therapy Co-Developed by Innovent and IASO Bio 2022-02-14 08:00
Ascletis Announces Submission of Marketing Authorization Applications for Ritonavir in Multiple European Countries 2022-02-13 18:30
Qilian International Holding Group Limited Reports Fiscal Year 2021 Financial Results 2022-02-12 06:05
Kintor Pharma Announces First Patient Dosing in China in Phase III Clinical Trial of Proxalutamide for the Treatment of COVID-19 Outpatients 2022-02-11 20:40
Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial 2022-02-11 10:45
FDA Advisory Committee Votes to Recommend Additional Data for Sintilimab Submission 2022-02-11 10:44
Alphamab Oncology Announced IND Approval of PD-L1/OX40 Bispecific Antibody KN052 2022-02-11 09:31
Ucello Therapeutics Completes US$25 Million Series A Financing 2022-02-11 02:16
1 195 196 197 198 199 416